111, Inc.
YI- Exchange
- Nasdaq
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001738906
In the last 90 days, 111, Inc. insiders filed 0 open-market purchases and 2 sales; 8 institutions reported holding it in 13F filings for Q2 2026, worth $498.4K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding 111, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 16 | 13 | −3 |
| Shares | 1.88M | 1.82M | −61.5K (−3.3%) |
| Value | $4.97M | $4.46M | −$508.7K (−10.2%) |
New holders (1)
Institutions that held 111, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhumbline Advisers | 5,245 | $12.9K | 0.00% |
Sold out (4)
Institutions that held 111, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Invesco Ltd. | 56,068 | $148.6K |
| Marshall Wace, LLP | 23,536 | $62.4K |
| Two Sigma Investments, LP | 17,500 | $46.4K |
| UBS Group AG | 692 | $1.83K |